• Skip to primary navigation
  • Skip to main content

New York Society of Addiction MedicineNew York Society of Addiction Medicine Logo

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn
  • Join Mailing List
  • Past Conferences
  • 2024 Annual Conference
  • About Addiction Medicine
  • Key Issues
    • Advocacy
    • Opioids
    • Marijuana
    • Access to Care
    • More Issues
  • About
    • About NYSAM
    • Leadership
    • Contact NYSAM
    • News
    • Annual Conference
  • Resources
    • For Patients
    • For Physicians
    • Webinars
    • Articles
    • Employment
  • Membership
    • NYSAM Committees
    • Become a NYSAM Member
    • Renew Membership
    • Our Members
  • Annual Conference
  • Past Conferences
  • Donate
  • Sign Up for Our Newsletter

Opioids

Opioids are a class of medications and substances that primarily affect the mu opioid receptor, in the central nervous system. Opioids comprise natural opiates and synthetic and semi-synthetic opioids. Opioids can have a medical purpose for the treatment of pain, like prescribed opioid medications. Opioids can also have a non-medical purpose such as heroin, a substance that can be ingested, inhaled, or injected.

September 25, 2019 by NYSAM

The NY Department of Health AIDS Institute Substance Use Guideline Committee Publishes New Guideline: Treatment of Opioid Use Disorder

Two new Substance Use Disorder Treatment Guidelines have just been released and posted on by the AIDS Institute Clinical Guidelines…

August 12, 2019 by Jasmine Landry

JAMA Article Response: Healthcare Providers Should Not Perpetuate Stigmatization

In a piece published in JAMA that discussed last year’s film Beautiful Boy, Dr. Abigail Zuger endorsed the sentiment of…

July 30, 2019 by NYSAM

ASAM Supports Expansion of Access to Buprenorphine Through The Mainstreaming Addiction Treatment Act

ASAM Board Member, Dr. Margaret Jarvis, testified in front of a Congressional Roundtable on the nation’s response to the “third…

July 23, 2019 by Edwin Salsitz

Addiction Medicine Medical Vocabulary

Language Matters We have witnessed remarkable progress in the understanding of the disease of addiction over the past two decades.…

July 16, 2019 by NYSAM

Commentary: Allow Proven Science to Guide Opioid Addiction Treatment

NYSAM board members Dr. Melissa Weimer and Dr. Jeffrey Selzer together with Dr. Daniel Schatz, adjunct assistant professor in the…

April 12, 2019 by Daniel Schatz, MD

Buprenorphine Best Practices

The New York State Department of Health, the New York State Office of Alcoholism and Substance Abuse (OASAS), and the New York State Buprenorphine Working Group wrote a Best Practice document focused on misconceptions related to the use of buprenorphine for the treatment of opioid use disorder (OUD). NYSAM Board Member, Dr. Dan Schatz, wrote a summary of the document reviewing five misconceptions of buprenorphine treatment.

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

View by Topic

  • All Topics
  • Access to Care
  • Advocacy
  • Alcohol
  • Benzodiazepines
  • Evidence-based Research
  • Harm reduction
  • Marijuana
  • Opioids
  • Stimulants

Connect with Us

  • NYSAM on Twitter
  • NYSAM on Facebook
  • NYSAM on LinkedIn

Join our mailing list to stay updated on upcoming events and chapter news.

  • This field is for validation purposes and should be left unchanged.

NYSAM is a State Chapter of the American Society of Addiction Medicine (ASAM)

  • Become a Member
  • About Addiction Medicine
  • Addiction Resources
  • Physician Resources
  • Key Issues
NYSAM logo in footer

865 Merrick Avenue
Westbury, NY 11590

For inquiries, contact Philip Schuh, CPA,MS, Executive Vice President MSSNY
516-488-6100, ext.397
nysocietyofaddictionmedicine@gmail.com

© 2023 New York Society of Addiction Medicine. Website by Status Forward.

Join the Conversation

Stay Informed. Share your views.

For the latest news and evidence on substance use disorders and addiction, follow NYSAM on Twitter.

Follow Us

×